Karuna Therapeutics Inc. (KRTX) Misses Q4 EPS by 33c

Karuna Therapeutics Inc. (NASDAQ: KRTX) reported Q4 EPS of ($3.01), $0.33 worse than the analyst estimate of ($2.68).

For earnings history and earnings-related data on Karuna Therapeutics Inc. (KRTX) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02